Articles Posted in Dangerous Products

Published on: March 4, 2025

The FDA Makes Announcements Related to Smoking and Nicotine Addiction

cigarette-7285317_640 2025 opened with announcements from the U.S. Food and Drug Administration (FDA) about cessation of smoking and the reduction of nicotine addiction. The first of the two announcements was a Notice of Proposed Rulemaking. This would call for a reduction in nicotine in combustible tobacco products to levels that are not addictive. This has been requested by public health advocates since 2009’s Family Smoking Prevention and Tobacco Control Act, which authorized such a change. The agency has set out a comment period that from January 16 all the way to September 15 of this year. However, the other announcement had to do with authorizing 3 mg and 6 mg nicotine content in a broader range of flavors of 20 Zyn nicotine pouches, which seems potentially dangerous for children. If your child was harmed by a nicotine pouch or other addictive nicotine product, call the knowledgeable product liability lawyers of Moll Law Group.

Consult the Trustworthy Moll Law Group About Your Nicotine Claim

In a time when the harms of nicotine to the body and brain, particularly on youth brain development, are increasingly clear, it seems surprising that the FDA would authorize 20 Zyn nicotine pouches in multiple attention-grabbing flavors like Peppermint, Chill, Smooth, Citrus, and Cinnamon. The second announcement seems to cut against the general tendency of the FDA to try to spur smoking cessation, such as by calling for reductions of nicotine in other products.

The agency justifies the decision allowing for greater marketing efforts with the claim that adults who use Zyn have switched entirely to those products to consume nicotine rather than smoke cigarettes or obtain smokeless tobacco. It claims that the Zyn products have less deleterious chemicals than those other products. It also argues that it will keep an eye on Zyn marketing to make sure the manufacturer is complying with the nuances of the marketing order—Zyn isn’t allowed to promote these products to children or teens, and the marketing order can be rescinded for noncompliance.

Continue reading →

Published on: December 17, 2024

Oxbryta Litigation Has Commenced

By Moll Law Group

treatment-4099432_6402-e1734460206805 Recently, a medication for sickle cell disease, Oxbryta, was voluntarily recalled because it can cause complications and death. Litigation has begun against Pfizer Inc. and its subsidiary Global Therapeutics. One plaintiff, a patient who underwent treatment, has alleged that the companies should have known that administration of the sickle cell treatment could result in a patient’s death. According to that plaintiff, he suffered a higher rate of vaso-occlusive crisis after he used the medication. Pfizer denies that it acted irresponsibly. If you were harmed by Oxbryta, give the seasoned Chicago-based dangerous drug lawyers of Moll Law Group a call.

Call Moll Law Group About Your Oxbryta Claim

Oxbryta is a drug that was meant to alleviate sick cell disease symptoms. It was formulated to prevent hemoglobin polymerization; this, in turn, stops the sickling of red blood cells and improving the ability for hemoglobin to be oxygenated. In 2019, the Food and Drug Administration (FDA) accelerated its approval for those patients who are at least 12-years-old. In 2021, the FDA approved the drug for children with the minimum age for use being age 4. Unfortunately, once the drug was used in the real world, certain side effects were dire. One of the complications that arose in connection with the drug were vaso-occlusive crises, painful incidents where the sickled blood cells obstruct the flow of blood through a patient’s body. Some patients died as a result of these complications.

Pfizer recalled the drug across the world in September 2024, due to this real-world data that indicated Oxbryta’s risks are greater than its potential benefits. Patients and family members brought many lawsuits against Pfizer, and many of these claimed that Pfizer and its subsidiary had failed to provide adequate warnings as to these risks and complications. In plain terms, they are arguing that the company didn’t let them know about the risk of suffering vaso-occlusive crises and death and this prevented doctors and patients from making informed decisions about whether or not to take the drug.

Continue reading →

Published on: October 22, 2024

Brain Tumors Linked to Depo-Provera

By Moll Law Group

injection-4544448_640 The drug company Pfizer manufactures the popular form of contraception Depo-Provera. It’s a contraceptive administered via an injection every three months; it suppresses ovulation and thickens cervical mucus to block sperm’s ability to get to the egg. However, studies have shown that there is a link between increased risk of brain tumors and Depo Provera, and this has resulted in an increased uptick in danger drug lawsuits filed. If you were harmed by Depo-Provera, you should call the seasoned Chicago-based product liability lawyers of Moll Law Group. Billions have been recovered in cases with which we’ve been involved.

Consult Attorneys at Moll Law Group

Many patients use hormonal birth control. One of these methods is Depo-Provera, an intramuscular injection of medroxyprogesterone acetate, a synthetic form of progesterone, into a buttock or arm. It impacts reproduction. The chances of getting pregnant are reduced through the alteration of the uterine lining and stop of ovulation. It’s more than 99% effective if it’s routinely given on schedule.

Depo-Provera has been connected to a patient’s increased risk of meningioma, which is a kind of brain tumor. In fact, studies have revealed that long-term use of Depo-Provera markedly ups the chances of developing these kinds of tumors. Specifically, the British Medical Journal has indicated a 5.6-fold increase in risk of intracranial tumors due to Depo-Provera—which can cause brain pressure that requires invasive surgery that carries severe health problems and complications. You may be especially vulnerable if you’ve used Depo-Provera for a lengthy time. The symptoms of meningioma you should look out for include hearing loss, seizures, vision problems, persistent headaches, and weakness. It’s noteworthy that other progestogens like levonorgestrel intrauterine systems and dydrogesterone don’t seem associated with an increased risk.

Continue reading →

Published on: June 18, 2024

CPSC Reports that Off-Highway Vehicle Deaths Have Increased by 33%

By Moll Law Group

atv-e1718066265390 Off-highway vehicle use typically increases during the summer months. Recently, the Consumer Product Safety Commission issued its annual report about rising off-highway deaths and injuries. Among other things, the report revealed that minors under age 16, as well as adults between the ages of 45 and 54 have higher death rates in off-highway vehicles. Overall, there was a 33% increase in off-highway vehicle deaths in 2020 compared to 2019—these were the two most recent years for which there was data. Males were disproportionately affected. The CPSC chair Alex Hoehn-Saric has asked that safe riding be put first and that riders should wear a helmet with proper gear.

Call Moll Law Group About Your Off-Highway Vehicle Lawsuit

The CPSC report asks rider to take appropriate steps to avoid collisions. Leading causes of death in off-highway vehicles were crashes with other vehicles and stationary objects like trees. Often the occupants of vehicles would be thrown out of the vehicle during these collisions.

The report also informs us that children under age 12 constituted 44% of fatalities of children under 16. Additionally, adults older than 55 were affected; they made up 30% of related deaths.

Continue reading →

Published on: April 24, 2024

Eli Lilly Received Approval for New Weight Loss Drug Zepbound

By Moll Law Group

belly-2354_1280-e1712682579349-300x200 There has been a huge uptick in the demand for weight loss drugs and as a result of new drug approvals, the supply has been impacted. Last fall, the drug manufacturer Eli Lilly received approval from the Food and Drug Administration (FDA) for a new medication for chronic weight management. The drug is known as Zepbound, and at $1059.87 for a month’s supply, it is cheaper than Wegovy, which is manufactured by Eli Lilly’s competitor Novo Nordisk. However, much of the excitement of Zepbound and Wegovy fails to appreciate the risks associated with these drugs. If you are a patient who has been harmed by Zepbound, you should call the seasoned dangerous drug Chicago-based attorneys of Moll Law Group. We represent people harmed around the country and billions have been recovered in lawsuits with which we’ve had involvement.

Consult Moll Law Group About Your Weight Loss Drug Lawsuit

The use of diabetes drugs for weight loss has gained increasing public attention. Initially, the FDA wouldn’t allow Eli Lilly to market the diabetes drug Mounjaro for obesity, but late last year, it approved Zepbound, which is based on the same active ingredient. You should be aware, however, that there still questions about long-term health risks of using these drugs.

Zepbound, or tirzepatide, is given as an injection for chronic weight management in patients that are obese or overweight with an additional weight-related condition. Around 70% of adults around the country are obese or overweight; being able to lose 5%-10% of their weight has been linked to a reduced danger of suffering cardiovascular disease. The same drug is marketed under the trade name Mounjaro for use by adults with type 2 diabetes mellitus to better their glucose levels. Mounjaro has been the subject of increasing numbers of product liability lawsuits brought by people who took the drug and allegedly experienced gallbladder and gastrointestinal complications necessitating further expensive medical treatment.

Continue reading →

Published on: May 23, 2023

Ivenix Infusion System Recall Issued Over Risk of Leaks

By Moll Law Group

treatment-ge2ec498b1_1280-e1683586667860 Recently, the United States Foods and Drug Administration (FDA) issued a recall for Fresenius’ Ivenix Infusion System. Over 1,500 infusion pumps have been found susceptible to leaks and electrical failures that can result in the pump turning off during a treatment that is normally lifesaving. These systems may be defective. If you were injured or a loved one died and you believe it was the result of an Ivenix infusion defect, you should call the seasoned Chicago-based product liability lawyers of Moll Law Group. We represent injured consumers nationwide. Billions have been recovered in lawsuits with which we’ve been involved.

Call Moll Law Group About Whether You Have an Infusion Lawsuit

The recalled system is a high-volume pump that hospital staff use to provide a patient with specific amounts of fluid to their veins, or beneath their skin, or in their spine. Patients who receive this care include adults, infants, children, teens, and neonates. The danger addressed by the recall is that the pump can leak fluids from the pump into what’s called the Administration Set Loading Area of the infusion system.

This poses a serious danger because that area is located by the Air detector, and when fluid hits the electrical parts of the infusion pump, it may go through an electrical short that leads the device to power down with so warning. There have been 14 reports arising out of this issue. No deaths were reported as of this writing, but officials have warned that delay of infusions to children who need them could cause serious injuries or deaths.

Continue reading →

Published on: April 11, 2023

Side Effects and Off Label Use of Ozempic

By Moll Law Group

hand-gb5c718cdb_640 Doctors have been concerned about off-label use of Ozempic due to the risks of suffering gallbladder disease in connection with the drug. If you suffered harm to your gallbladder or other injuries and suspect they are the result of taking Ozempic, you should call the experienced Chicago-based product liability lawyers of Moll Law Group. Billions have been recovered in dangerous drug lawsuits with which we’ve been involved across the state.

Call Moll Law Group About Your Claim

The prescription drug Ozempic is a liquid inside pre-filled disposable pens that is used to control the blood sugar of adult type 2 diabetes patients. Semaglutide is the active ingredient of Ozempic. There is no generic form provided of the drug.

Ozempic is injected beneath the skin. Generally, adults have been advised to combine Ozempic with lifestyle improvements. The drug also lowers the chance of suffering stroke or heart attack. However, the drug is not recommended for type 1 diabetics, those with diabetic ketoacidosis, or those who have had pancreatitis. And Ozempic’s connection to gallbladder trouble may make it risky to use.

Continue reading →

Published on: February 21, 2023

Several Brands of Children’s Pajamas Recalled Over Fire-Safety Concerns

By Moll Law Group

Recently, the Consumer Product Safety Commission posted notice of several recalls involving children’s pajamas. While the recalls involved various manufacturers, the products were widely available online through major retailers such as Amazon, Uncommon Goods, and Macy’s, as well as in boutique stores nationwide.

Why Are Children’s Pajamas Being Recalled?

According to various posts on the Consumer Product Safety Commission (“CPSC”) website, the manufacturers of the pajama sets issued the recalls because they failed to meet the federal flammability standards for children’s sleepwear. Under existing regulations, all children’s sleepwear for children over the age of nine months must be either flame-resistant or tight-fitting. Tight-fitting pajamas do not need to be flame-resistant because close-fitting clothes pose a much lower risk of catching fire. All children’s pajamas that were recently recalled were not tight-fitting and failed to comply with the CPSC’s flame-resistant requirements.

Which Children’s Pajamas Were Recalled?

While many brands of children’s pajamas have been subject to recalls over recent months, the most recent group of recalls affects the following brands:

Continue reading →

Published on: February 13, 2023

4.7 Million Fisher-Price Rock ‘n Play Sleepers Recalled

By Moll Law Group

Child in pajamas Fisher-Price recently recalled its Rock ‘n Play Sleepers. The sleepers are made for infants, and they allow for parents to place their babies in bassinet-like beds designed for easy and comfortable sleeping. These sleepers were recalled because infants have tragically died while rolling from their backs to their stomachs or sides while unrestrained. Consumers have been advised to immediately stop using the strollers and to get a refund from Fisher-Price if they own the sleeper. If your child was injured due to an experience with the Rock ‘n Play, you should give the liability lawyers of Moll Law Group a call as soon as possible. Thanks to our team, billions have been recovered in lawsuits after consumer injuries just like these.

Details of the Recalled Fish ‘n Play Product

Approximately 100 deaths have occurred in connection with this Fisher-Price product. Apparently, the deaths have almost always happened when infants have rolled around while in the sleepers, partially because the infants have been entirely unrestrained. Fisher-Price reported that in several of the reported instances, it has been unable to confirm the exact circumstances that caused the related death or injury.

Affected sleepers were sold at Walmart, Target, and online at Amazon. Fisher-Price put the product on the market in September 2009, and they have been sold for anywhere between $40 and $149 since then. As of January 9, 2023, it is illegal to sell or distribute the recalled product. All models of the Rock ‘n Play sleeper have been recalled. To receive a refund for the Fish ‘n Play, consumers can go to Fisher-Price website and submit a claim. The Consumer Product Safety Commission estimates that more than 4.7 million of the recalled Rock ‘n Play sleepers have been sold to U.S. consumers.

Continue reading →

Published on: February 6, 2023

LG Recalls 86-Inch Smart Televisions and Stands Due to Fall Hazards

By Moll Law Group

LG recently recalled its 86-inch smart televisions and stands. According to consumer reports, the TV can become unstable and cause serious tip-over hazards to consumers. Because of this injury risk, the company recalled the product on January 12, 2023. If you have been injured while using this TV, give us a call at the Moll Law Group as soon as possible. We take great care in representing those that have been injured in situations just like these, and we offer personalized solutions that can get you compensated for your injuries.

Baby near TV The LG 86-Inch Smart TV and Stand

Approximately 52,000 of the recalled TVs and stands have been sold in the United States, while 1,800 have been sold in Canada and 2,900 have been sold in Mexico. The recall involves four specific models that each weigh approximately 100 pounds. LG is recalling the product because 22 consumers have reported that the TV stand is unstable; 12 of these consumers reported that the TV has actually tipped over while on the stand. Fortunately, at this point, no injuries have been reported.

If you own one of these TVs, you should immediately take it off the stand and put it in a spot away from kids or other individuals that could be more at risk of injury. Consumers that have their TVs mounted to the wall can continue using their TVs as they have historically used them, as the recall does not impact the safety of wall-mounted units.

The TVs have been sold both in person and online at major retailers such as Walmart, Best Buy, Costco, and Amazon. LG first put the TVs and stands on the market in March 2022, and consumers typically pay anywhere from $1,100 to $1,900 for the product.

Continue reading →